Table 3.
Comparison of symptoms between the VR-CALM group and the CAU group of breast cancer patients before and after VR-CALM or CAU.
| Group | N | FACT-B | DT | SAS | SDS | CARS | PFS | PSQI |
|---|---|---|---|---|---|---|---|---|
| Before VR-CALM or CAU | ||||||||
| VR-CALM | 38 | 78.74 ± 10.125 | 5.71 ± 1.250 | 51.66 ± 11.252 | 51.32 ± 11.552 | 59.34 ± 13.581 | 103.03 ± 8.645 | 10.45 ± 3.438 |
| CAU | 39 | 75.44 ± 10.39 | 6.13 ± 0.695 | 49.31 ± 6.814 | 48.64 ± 4.934 | 55.00 ± 4.605 | 101.62 ± 9.35 | 10.05 ± 3.426 |
| t | 1.411 | −1.806 | 1.105 | 1.315 | 1.869 | 0.687 | 0.506 | |
| p | 0.162 | 0.076 | 0.273 | 0.194 | 0.068 | 0.494 | 0.614 | |
| After VR-CALM or CAU | ||||||||
| VR-CALM | 38 | 100.47 ± 14.33 | 2.95 ± 1.845 | 44.16 ± 11.083 | 46.63 ± 9.824 | 55.82 ± 10.557 | 77.79 ± 11.548 | 8.74 ± 2.565 |
| CAU | 39 | 79.44 ± 6.703 | 5.49 ± 1.393 | 55.21 ± 3.806 | 50.21 ± 3.806 | 53.49 ± 6.328 | 99.77 ± 6.964 | 11.26 ± 4.494 |
| t | 8.216 | −6.829 | −5.819 | −2.094 | 1.170 | −10.082 | −3.031 | |
| p | ≤0.001 | ≤0.001 | ≤0.001 | ≤0.05 | 0.247 | ≤0.001 | ≤0.01 | |
Note. FACT-B, Functional Assessment of Cancer Therapy-Breast cancer patient; DT, Distress Thermometer; SAS, The Self-Rating Anxiety Scale; SDS, The Self-Rating Depression Scale; CARS, Concerns About Recurrence Scale; PFS, Piper Fatigue Scale; PSQI, Pittsburgh Sleep Quality Index; SD, standard deviation. Data are presented as mean ± SD.